MedTrace Logo

Electrolyte and Fluid Disturbances in Subarachnoid Hemorrhage and Traumatic Brain Injury

NCT01313975 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 85

Last updated 2013-04-17

No results posted yet for this study

Summary

During the course of their acute illness patients with subarachnoid hemorrhage and severe traumatic brain injury often develop disturbances in their fluid balance and electrolyte homeostasis. These shifts are associated with worse outcome and increased morbidity.

The aim of this observational study is to systematically analyze the incidence, characteristics, potential diagnostic markers and predisposing factors of such disturbances. The investigators hypothesize that many disturbances cannot be classified with a standard diagnostic approach and that variable fluid management contributes to their pathophysiology.

Patients will be closely monitored clinically and the exact fluid and electrolyte balances will be recorded. Treatment decisions are within the bedside physicians responsibility. Baseline fluid management is standardised. No interventions are planned. The observation period equal the duration of ICU stay.

Conditions

Sponsors & Collaborators

  • Foundation for research in Anaesthesie and Intensive Care Medicine

    collaborator UNKNOWN

  • Brahms AG

    collaborator INDUSTRY

  • Insel Gruppe AG, University Hospital Bern

    lead OTHER

Principal Investigators

  • Jan Wiegand, MD · Dep. Intensive Care Medicine, University Hospitals Bern

  • Stephan Jakob, MD, PhD · Dep. Intensive Care Medicine, University Hospitals Bern

  • Jukka Takala, MD PhD · Dep. Intensive Care Medicine, University Hospitals Bern

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2011-01-31
Primary Completion
2013-01-31
Completion
2013-01-31

Countries

  • Switzerland

Study Locations

More Related Trials

Entities

Diseases

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01313975 on ClinicalTrials.gov